TY  - JOUR
AU  - Mantovani, Alessandro
AU  - Zusi, Chiara
PY  - 2019
TI  - The dawn of a new era for nonalcoholic fatty liver disease?
JF  - Hepatobiliary Surgery and Nutrition; Vol 8, No 6 (December 13, 2019): Hepatobiliary Surgery and Nutrition (Special Focus on Precision Medicine of Cholangiocarcinoma)
Y2  - 2019
KW  - 
N2  - Non-alcoholic fatty liver disease (NAFLD) has become the most frequent chronic liver disease in several developed and developing countries, affecting roughly 30% of adults in the general population, 65–70% of individuals with type 2 diabetes mellitus and, virtually, all patients with obesity (1). Of note, its prevalence is believed to rise dramatically over the next decade, along with an increase of prevalence in obesity, diabetes mellitus and metabolic syndrome.
UR  - https://hbsn.amegroups.org/article/view/30292